Week In Review: BeiGene Raises $97 Million For Cancer Drugs By: TalkMarkets May 16, 2015 at 17:31 PM EDT BeiGene, a Beijing biopharma focused on developing novel targeted and immuno-oncology cancer therapies, completed a $97 million fundraising. Read More >> Related Stocks: Eli Lilly